Search
Menu
Home
HTB
2002
September
HTB
September 2002
Contents
On the web
‘Natural’ resistance to HIV: is the evidence good enough to design an effective vaccine?
Insights into HIV-specific CD4+ T cell immunity
Cytomegalovirus: update
The switching spiral: a triumph of hope over benefit?
Peripheral neuropathy
The push for once-daily HAART: a call for caution
Enhancing adherence to antiretrovirals: strategies and regimens
High doses of riboflavin and thiamine may help in secondary prevention of hyperlactatemia
HAART and prevention of HIV transmission
PDFs
Volume 3 Number 7 August/September 2002 PDF
Post navigation
Newer articles
HTB RSS
Early access
Bipolar disorder in people living with HIV
31 October 2024
Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic
29 October 2024
Mpox breakthrough cases after two doses of the MVA-BN vaccine
29 October 2024
All early access reports
Current issues
October 2024
September 2024
August 2024
Back issues
Special report
HIV diagnoses in England jump by 51% in 2023: missing targets and highlighting disparities in access to care
6 October 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate